Cargando...
Is metastatic pancreatic cancer an untargetable malignancy?
Metastatic pancreatic cancer (MPC) is one of the most aggressive malignancies, known to be chemo-resistant and have been recently considered resistant to some targeted therapies (TT). Erlotinib combined to gemcitabine is the only targeted therapy that showed an overall survival benefit in MPC. New t...
Gardado en:
| Publicado en: | World J Gastrointest Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Baishideng Publishing Group Inc
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4789615/ https://ncbi.nlm.nih.gov/pubmed/26989465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v8.i3.297 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|